Pharma Journalist -

Code Biotherapeutics, Inc. (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, announced a collaboration and option agreement with Takeda to…
Read More...

Eli Lilly and Company announced the launch of the Lilly Institute for Genetic Medicine and an investment of approximately $700 million to establish a state-of-the-art facility at a new…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Data and Safety Monitoring Board (DSMB) for the RSV program has…
Read More...

Actinium Pharmaceuticals, Inc. and AVEO Oncology announced that they have entered into a research collaboration to develop and study a first-in-class antibody radio-conjugate (ARC)…
Read More...

Valneva SE a specialty vaccine company, today announced that its subsidiary Valneva Scotland has been awarded research and development funding of up to £20 million by Scottish…
Read More...

Prestige BioPharma Limited, a Singapore-based biopharmaceutical with operations in USA and South Korea, announced that the manufacturing facility for its Herceptin biosimilar, Tuznue,…
Read More...

CARsgen Therapeutics Holdings Limited, a company focused on innovative CAR T-cell therapies announced that its current Good Manufacturing Practices (cGMP) manufacturing facility located…
Read More...

CEPI, the Coalition for Epidemic Preparedness Innovations, announced the latest award under its $200m programme, launched in March 2021, to advance the development of vaccines that…
Read More...

First HER2-low metastatic breast cancer Phase III results for AstraZeneca and Daiichi Sankyo’s Enhertu offer potential to redefine how the disease is classified and treated…
Read More...

BioNTech SE and Medigene AG, a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announced that they have entered a multi-target research…
Read More...